Market research

Laboratory Sample Management Software

Explore licenses

360iResearch introduction

Laboratory Sample Management Software: Executive Overview

Laboratory sample management software supports the registration, tracking, storage, processing, and disposition of samples across research, testing, clinical, industrial, and quality-control environments. Its core value lies in connecting sample identity, chain of custody, metadata, workflows, users, instruments, and results in a controlled digital record. Adoption is shaped by requirements for traceability, data integrity, operational efficiency, interoperability, and compliance rather than by a single laboratory use case.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to explore its complete hierarchy.

  1. Chapter 7 Component

    • Software
    • Services
    View chapter
  2. Chapter 8 Sample Type

    • Biological Samples
    • Non-Biological Samples
    View chapter
  3. Chapter 9 Functionality

    • Sample Lifecycle Management
    • Workflow & Process Management
    • Sample Tracking & Traceability
    • Storage & Location Management
    More in this chapter

From Manual Tracking to Connected, Compliant Workflows

Laboratories are moving away from paper records, spreadsheets, and isolated departmental tools toward centralized workflows that standardize accessioning, labeling, location management, transfers, approvals, and retention. Barcode and radio-frequency identification capabilities can reduce transcription errors, while configurable workflows help laboratories accommodate varied protocols without weakening governance. Cloud deployment, mobile access, electronic signatures, audit trails, and integration with laboratory information management, electronic laboratory notebook, enterprise resource planning, and instrument systems are also reshaping implementation priorities. The main organizational challenge is balancing standardization with the flexibility required by different scientific and regulatory processes.

Artificial Intelligence Expands Automation, Not Accountability

Artificial intelligence can augment sample management through metadata classification, anomaly detection, duplicate identification, predictive maintenance signals, workflow prioritization, natural-language search, and automated quality checks. These capabilities are most useful when built on consistent identifiers, complete metadata, well-controlled vocabularies, and interoperable records. AI does not remove the need for validated procedures, human review, access controls, model monitoring, and explainable decision pathways. Laboratories therefore benefit from treating AI as a governed layer over reliable sample data rather than as a substitute for foundational data management.

Regional Dynamics: Regulation, Infrastructure, and Digitization Shape Adoption

North America is characterized by mature laboratory informatics practices, extensive research and healthcare activity, and strong expectations for auditability and system integration. Latin America shows opportunities linked to modernization, expanding testing capacity, and the replacement of fragmented records, while connectivity, procurement constraints, and uneven digital maturity can affect deployment. Europe places particular emphasis on privacy, data integrity, interoperability, and regulated workflows across diverse national systems. The Middle East is pursuing laboratory modernization alongside broader digital-health and research initiatives, with implementation influenced by localization and infrastructure requirements. Africa presents varied conditions, including urgent needs for reliable traceability and inventory control alongside resource, connectivity, and skills constraints. Asia-Pacific combines advanced laboratory ecosystems with rapidly digitizing research, manufacturing, and healthcare environments, making scalable and locally adaptable workflows important.

Group Insights: Shared Standards Meet Different Operating Contexts

ASEAN laboratories often need interoperable platforms that can accommodate varied regulatory environments, multilingual operations, and uneven infrastructure across member states. BRICS economies represent diverse laboratory and manufacturing systems, with common interest in reducing fragmentation, strengthening domestic capabilities, and improving traceability. The European Union emphasizes cross-border data governance, privacy, quality systems, and interoperability. G7 organizations generally operate in mature compliance and research environments where integration, cybersecurity, validation, and lifecycle governance are central concerns. GCC countries are investing in digitally enabled healthcare, research, and industrial capacity, increasing demand for scalable systems and localized implementation support. NATO members share heightened attention to resilience, cybersecurity, continuity, and trusted data exchange, particularly where laboratories support public-sector, health, or security-sensitive activities.

Country Insights: National Priorities Influence Implementation

Australia emphasizes research quality, healthcare interoperability, and geographically distributed operations. Brazil is addressing laboratory modernization across healthcare, agriculture, industry, and research, with local compliance and integration needs influencing adoption. Canada prioritizes privacy, research governance, and interoperability across institutions and jurisdictions. China combines large-scale research and manufacturing activity with strong interest in digital control, localization, and operational standardization. France and Germany place substantial weight on regulated processes, data protection, validation, and integration with established laboratory infrastructure. India is expanding digital laboratory capabilities across pharmaceuticals, healthcare, research, and manufacturing while managing diverse organizational maturity. Italy and Spain are modernizing laboratory operations within broader European governance requirements. Japan values precision, reliability, workflow discipline, and integration with advanced instrumentation. Mexico is pursuing greater traceability and digitalization across testing, healthcare, and industrial laboratories. Russia’s laboratory environments are shaped by domestic infrastructure, regulatory conditions, and continuity requirements. South Korea combines advanced technology adoption with strong manufacturing, healthcare, and research capabilities. The United Kingdom emphasizes data integrity, validation, interoperability, and governance across regulated and research settings. The United States has broad demand for connected sample workflows across life sciences, healthcare, environmental testing, and industrial quality operations, with cybersecurity and regulatory controls remaining central.

Priorities for Leaders: Build a Governed, Interoperable Sample Data Foundation

Industry leaders should begin with a documented inventory of sample journeys, failure points, regulatory obligations, and integration dependencies. They should define a common identifier and metadata model before automating complex workflows, then prioritize high-risk activities such as chain of custody, storage conditions, approvals, and disposition. Deployment plans should include role-based access, audit trails, electronic signatures where appropriate, retention rules, backup and recovery, cybersecurity controls, and validation evidence. Interoperability should be tested with instruments and adjacent laboratory systems using representative workflows rather than assumed from interface availability. AI initiatives should start with bounded, measurable use cases and human oversight. Finally, leaders should establish adoption metrics covering data completeness, processing time, exception rates, retrieval accuracy, instrument utilization, and user adherence, while maintaining a structured change-management and training program.

Methodology: Evidence-Based Assessment of Laboratory Workflow Requirements

This executive summary uses the defined market scope-laboratory sample management software-and synthesizes established operational, regulatory, technological, and geographic considerations relevant to the category. The assessment organizes evidence around sample lifecycle activities, data integrity, interoperability, automation, cybersecurity, artificial intelligence, and implementation readiness. Regional, group, and country observations are framed as qualitative comparisons of laboratory infrastructure, governance environments, digitization priorities, and operating conditions. No market estimates, market shares, forecasts, or company-level claims are used. Interpretations should be validated against current national regulations, institutional requirements, procurement conditions, and laboratory-specific workflows before investment decisions are made.

Conclusion: Traceability and Trusted Data Define Sustainable Value

Laboratory sample management software is becoming a foundational control layer for laboratories that need dependable traceability, coordinated workflows, and defensible data. The strongest outcomes will come from combining disciplined sample and metadata governance with interoperable architecture, secure deployment, validated automation, and user-centered implementation. Regional and national differences require configurable operating models, but the underlying priorities are consistent: identify every sample accurately, preserve its context and history, connect it to the right process and result, and make decisions from trusted records. Artificial intelligence can extend these capabilities when introduced within that governed foundation.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Laboratory Sample Management Software Market, by Component
    1. 7.1Introduction
    2. 7.2Software
      1. 7.2.1Biobank Management Software
      2. 7.2.2Laboratory Information Management System (LIMS)
      3. 7.2.3Standalone Sample Management System
      4. 7.2.4Electronic Lab Notebook Platforms
    3. 7.3Services
      1. 7.3.1System Integration Services
      2. 7.3.2Maintenance & Support Services
      3. 7.3.3Implementation & Installation Services
  8. 8.Laboratory Sample Management Software Market, by Sample Type
    1. 8.1Introduction
    2. 8.2Biological Samples
      1. 8.2.1Tissue & Biopsy
      2. 8.2.2Cell Cultures
      3. 8.2.3DNA & RNA
      4. 8.2.4Microbial Isolates
      5. 8.2.5Blood & Plasma
    3. 8.3Non-Biological Samples
      1. 8.3.1Chemical Compounds
      2. 8.3.2Environmental Samples
      3. 8.3.3Food & Ingredient Samples
  9. 9.Laboratory Sample Management Software Market, by Functionality
    1. 9.1Introduction
    2. 9.2Sample Lifecycle Management
    3. 9.3Workflow & Process Management
    4. 9.4Sample Tracking & Traceability
    5. 9.5Storage & Location Management
    6. 9.6Alerts & Notifications
  10. 10.Laboratory Sample Management Software Market, by Laboratory Type
    1. 10.1Introduction
    2. 10.2Clinical Laboratory
    3. 10.3Research Laboratory
    4. 10.4Quality Control Laboratory
    5. 10.5Forensic Laboratory
    6. 10.6Biorepository / Biobank
  11. 11.Laboratory Sample Management Software Market, by Deployment Type
    1. 11.1Introduction
    2. 11.2Cloud
    3. 11.3Hybrid
    4. 11.4On Premises
  12. 12.Laboratory Sample Management Software Market, by Organization Size
    1. 12.1Introduction
    2. 12.2Large Enterprise
    3. 12.3Small & Medium Enterprise
  13. 13.Laboratory Sample Management Software Market, by End User
    1. 13.1Introduction
    2. 13.2Hospitals & Diagnostic Centers
    3. 13.3Pharmaceutical & Biotechnology Companies
    4. 13.4Food Testing Companies
    5. 13.5Environmental Agencies
    6. 13.6Academic & Research Institutions
    7. 13.7Government & Public Health Laboratories
  14. 14.Laboratory Sample Management Software Market, by Region
    1. 14.1Introduction
    2. 14.2North America
    3. 14.3Asia-Pacific
    4. 14.4Europe
    5. 14.5Latin America
    6. 14.6Middle East
    7. 14.7Africa
  15. 15.Laboratory Sample Management Software Market, by Group
    1. 15.1Introduction
    2. 15.2NATO
    3. 15.3G7
    4. 15.4European Union
    5. 15.5BRICS
    6. 15.6ASEAN
    7. 15.7GCC
  16. 16.Laboratory Sample Management Software Market, by Country
    1. 16.1Introduction
    2. 16.2United States
    3. 16.3United Kingdom
    4. 16.4China
    5. 16.5India
    6. 16.6Germany
    7. 16.7Japan
    8. 16.8Canada
    9. 16.9South Korea
    10. 16.10France
    11. 16.11Australia
    12. 16.12Mexico
    13. 16.13Brazil
    14. 16.14Spain
    15. 16.15Italy
    16. 16.16Russia
  17. 17.Competitive Landscape
    1. 17.1Market Share Analysis, 2025
    2. 17.2Market Concentration Analysis, 2025
      1. 17.2.1Concentration Ratio (CR)
      2. 17.2.2Herfindahl Hirschman Index (HHI)
    3. 17.3Recent Developments & Impact Analysis, 2025
    4. 17.4Product Portfolio Analysis, 2025
    5. 17.5Benchmarking Analysis, 2025
  18. 18.Company Profiles
    1. 18.1Thermo Fisher Scientific Inc.
    2. 18.2LabWare, Inc.
    3. 18.3LabVantage Solutions, Inc.
    4. 18.4Abbott Laboratories
    5. 18.5F. Hoffmann-La Roche Ltd.
    6. 18.6Illumina, Inc.
    7. 18.7Oracle Corporation
    8. 18.8Benchling
    9. 18.9Agile Frameworks, LLC
    10. 18.10Semaphore Solutions Inc.
    11. 18.11QBench Inc.
    12. 18.12Eusoft S.r.l.
    13. 18.13TenderHut Group
    14. 18.14LabLynx, Inc.
    15. 18.15ABI Health
    16. 18.16Apex Healthware
    17. 18.17Autoscribe Informatics by Xybion Digital Inc.
    18. 18.18Capterra, Inc.
    19. 18.19Clinisys, Inc. by Roper Technologies, Inc.
    20. 18.20CloudLIMS
    21. 18.21CrelioHealth Inc.
    22. 18.22Labguru
    23. 18.23LabKey Software
    24. 18.24Labworks
    25. 18.25Opvia ltd.
    26. 18.26SciNote LLC
  19. 19.Key Experts

Loading the sample request form…